Genmab AS

Genmab AS Current Assets

Current Assets of Genmab AS (GMAB) as of Nov 22, 2026.

Current Assets

-USD

Last updated:

Current Assets of Genmab AS is 2026 - USD. Current Assets of Genmab AS was 2025 - USD. It decreases by % lower compared to the previous year.

The Genmab AS Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2002
1.42 B USD
Jan 1, 2003
1.07 B USD
Jan 1, 2004
1.19 B USD
Jan 1, 2005
1.32 B USD
Jan 1, 2006
1.77 B USD
Jan 1, 2007
3.70 B USD
The Genmab AS Current Assets history
YEARCurrent AssetsYoY
3.70 BUSD+108.96%
1.77 BUSD+33.84%
1.32 BUSD+10.99%
1.19 BUSD+11.68%
1.07 BUSD-24.75%
1.42 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

On Eulerpool you can find the complete historical development of Current Assets Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genmab AS

All Key Metrics — Genmab AS